BCL2L1 and non-Hodgkin lymphoma: Overexpression of antiapoptotic proteins such as Bcl-2, Bcl-XL, and Mcl-1 has found to be associated with drug resistance in human tumor cell lines [17–19], including leukemia [17] and NHL cells [20–23].